Spiramycin
Spiramycin (CAS 8025-81-8) is a potent macrolide antibiotic produced by Streptomyces ambofaciens, widely used for its exceptional tissue accumulation and antimicrobial efficacy.
Description
Comprehensive Product Overview
In the competitive landscape of infectious disease management, the ability to maintain high intracellular concentrations defines the final outcome. Zyntex Spiramycin is selected for its unique pharmacokinetic profile, which allows it to concentrate heavily in tissues such as the lungs, tonsils, and placenta. Therefore, we provide a high-purity crystalline powder that acts as a robust bacteriostatic agent by inhibiting protein synthesis through binding to the 50S ribosomal subunit. Consequently, this versatile ingredient delivers reliable performance across a wide range of clinical conditions, ensuring the effective treatment of toxoplasmosis during pregnancy and various respiratory tract infections.
Zyntex supplies Spiramycin in a clean, white to slightly yellowish powder form, optimized for easy integration into complex pharmaceutical synthesis, including oral tablets, capsules, and specialized veterinary injections. Our stringent quality control measures ensure a precise impurity profile and excellent stability against enzymatic degradation. Furthermore, this product features a long half-life, providing a sustained “post-antibiotic effect.” Since it is effective at clearing parasitic and bacterial pathogens without high systemic toxicity, you can incorporate it into various sensitive therapeutic protocols without affecting the metabolic safety or the absorption rate of the final dosage form.
From specialized laboratory research to large-scale pharmaceutical manufacturing, this versatile 16-membered macrolide is a staple for modern anti-infective therapy. Its consistent chemical profile ensures it functions effectively as a first-line defense against Cryptosporidium and Toxoplasma gondii. As a result, Zyntex provides a dependable foundation for innovation in the “maternal-fetal medicine” and “livestock health” markets. Finally, our commitment to chemical quality helps your brand achieve international pharmaceutical regulatory and safety standards effortlessly.
Key Industrial Applications
This professional-grade macrolide API is widely utilized in the following sectors:
🤰 Maternal Health
The gold-standard treatment for preventing the vertical transmission of toxoplasmosis from mother to fetus.
🐄 Veterinary Science
Extensively used to treat mastitis in cattle and respiratory mycoplasmosis in poultry and swine.
🦷 Odontological Care
Often formulated for acute dental infections due to its high concentration in salivary glands and bone tissue.
🧪 Pharmacological R&D
Used as a reference standard in studies involving ribosomal inhibition and parasitic life-cycle disruption.
Technical Specifications
| Parameter | Specification Standard |
|---|---|
| Product Name | Spiramycin |
| Potency (Dry Basis) | Min. 3900 IU/mg |
| Physical State | White to Off-White Powder |
| Specific Rotation | -80° to -85° |
| CAS Number | 8025-81-8 |
🔬 Scientific Data: For detailed molecular structure, tissue distribution studies, and toxicological profiles, consult: PubChem Entry: Spiramycin (External Link)
